Schedule of Warrants Activity (Details) - $ / shares |
3 Months Ended | 12 Months Ended |
|---|---|---|
Mar. 31, 2022 |
Dec. 31, 2021 |
|
| Warrants | ||
| Warrants, beginning balance | 18,040,572 | 20,513,145 |
| Weighted average price, beginning balance | $ 1.42 | $ 1.36 |
| Warrants, Granted | ||
| Weighted average price, Granted | ||
| Warrants, Exercised | (2,472,573) | |
| Weighted average price, Exercised | $ 0.91 | |
| Warrants, Expired | ||
| Weighted average price Expired | ||
| Warrants, Exercised | 2,472,573 | |
| Warrants, ending balance | 18,040,572 | 18,040,572 |
| Weighted average price ending balance | $ 1.42 | $ 1.42 |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Weighted average price at which non-option equity holders acquired shares when converting their non-option equity into shares. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non option equity instruments expired in period weighted average exercise price. No definition available.
|
| X | ||||||||||
- Definition Weighted average per share amount at which grantees can acquire shares of common stock by exercise of non-option equity. No definition available.
|
| X | ||||||||||
- Definition Weighted average price at which grantees can acquire the shares reserved for issuance under the stock non-option equity plan. No definition available.
|
| X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements for which rights to exercise lapsed. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|